BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Arcalyst rilonacept regulatory update

FDA accepted for review an sBLA from Regeneron for Arcalyst rilonacept to prevent gout flares in patients initiating uric acid-lowering therapy. The PDUFA date is...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >